This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.




Hypoxia-Inducible factor 1 alpha inhibitor

From Proteopedia

Jump to: navigation, search

Structure of FIH-1 dimer (cyan, green) complex with HIF-1 C-terminal transactivation domain (pink, magenta), oxalylglycine, sulphate and Zn+2 ion (grey) (PDB code 1h2m)

Drag the structure with the mouse to rotate

3D Structures of Hypoxia-Inducible factor 1 alpha inhibitor

Updated on 17-September-2025 {{#tree:id=OrganizedByTopic|openlevels=0|

  • Hypoxia-inducible factor 1 alpha inhibitor
  • Hypoxia-inducible factor 1 alpha inhibitor complex with peptide
    • 2xum – hFIH-1 (mutant) + peptide
    • 1h2l – hFIH-1 + HIF-1 peptide + glutarate derivative
    • 2ilm, 3d8c, 5jwp – hFIH-1 (mutant) + HIF-1 peptide + glutarate derivative
    • 2y0i, 7a1s – hFIH-13 + tankyrase-2 peptide + glutarate derivative
    • 3p3n, 3p3p – hFIH-1 + notch 1 peptide + glutarate derivative
    • 4z1v – hFIH-1 + oxalylglycine
    • 1h2k, 1h2m – hFIH-1 + HIF-1 peptide + oxalylglycine
    • 6h9j, 6ha6 – hFIH-1 + TRPV3 peptide + oxalylglycine
    • 6hc8 – hFIH-1 + TRPA1 peptide + oxalylglycine
    • 6hl5, 6hl6 – hFIH-1 + ASPP1 peptide + oxalylglycine
    • 6hkp – hFIH-1 + ASPP2 peptide + oxalylglycine
    • 4b7e, 4b7k, 4jaa, 4rn1, 6ruj – hFIH-1 + concensus Ankyrin-repeat domain peptide + oxalylglycine
    • 7a1n, 7a1o, 7a1p, 7a1q – hFIH-1 + concensus Ankyrin-repeat domain peptide + oxoglutaraste derivative

}}

References

  1. Mahon PC, Hirota K, Semenza GL. FIH-1: a novel protein that interacts with HIF-1alpha and VHL to mediate repression of HIF-1 transcriptional activity. Genes Dev. 2001 Oct 15;15(20):2675-86. PMID:11641274 doi:http://dx.doi.org/10.1101/gad.924501
  2. Kiriakidis S, Henze AT, Kruszynska-Ziaja I, Skobridis K, Theodorou V, Paleolog EM, Mazzone M. Factor-inhibiting HIF-1 (FIH-1) is required for human vascular endothelial cell survival. FASEB J. 2015 Jul;29(7):2814-27. doi: 10.1096/fj.14-252379. Epub 2015 Apr 2. PMID:25837583 doi:http://dx.doi.org/10.1096/fj.14-252379
  3. Chen T, Ren Z, Ye LC, Zhou PH, Xu JM, Shi Q, Yao LQ, Zhong YS. Factor inhibiting HIF1alpha (FIH-1) functions as a tumor suppressor in human colorectal cancer by repressing HIF1alpha pathway. Cancer Biol Ther. 2015;16(2):244-52. doi: 10.1080/15384047.2014.1002346. PMID:25602156 doi:http://dx.doi.org/10.1080/15384047.2014.1002346
  4. Elkins JM, Hewitson KS, McNeill LA, Seibel JF, Schlemminger I, Pugh CW, Ratcliffe PJ, Schofield CJ. Structure of factor-inhibiting hypoxia-inducible factor (HIF) reveals mechanism of oxidative modification of HIF-1 alpha. J Biol Chem. 2003 Jan 17;278(3):1802-6. Epub 2002 Nov 21. PMID:12446723 doi:http://dx.doi.org/10.1074/jbc.C200644200

Proteopedia Page Contributors and Editors (what is this?)

Michal Harel, Alexander Berchansky

Personal tools